Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
European Urology Oncology|September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center AnalysisMike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
Plos One|August 3, 2017
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancerKathrin Endt, Jens Goepfert, Aurelius Omlin, et al.
The Prostate|August 16, 2022
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health indexDaniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, et al.
The Journal of Sexual Medicine|January 16, 2009
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomyGeorg Salomon, Hendrik Isbarn, Lars Budaeus, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|May 7, 2024
Impact of COVID-19 on the time to counseling and treatment of prostate cancerDejan K Filipas, Randi M Pose, Phillip Marks, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Aktuelle Urologie|June 1, 2021
[Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance]Marie Christine Hupe, Marten Müller, Julian Peter Struck, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
Aktuelle Urologie|September 24, 2020
[CARD study: relevance for the treatment of advanced prostate cancer]Axel S Merseburger, Andreas Bannowsky, Klaus Becker, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
BJU International|October 15, 2010
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory studyThomas Steuber, Lars Budäus, Jochen Walz, et al.
European Urology Oncology|September 1, 2024
Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center AnalysisMike Wenzel, Cristiana Cano Garcia, Clara Humke, et al.
Plos One|August 3, 2017
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancerKathrin Endt, Jens Goepfert, Aurelius Omlin, et al.
The Prostate|August 16, 2022
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health indexDaniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, et al.
The Journal of Sexual Medicine|January 16, 2009
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomyGeorg Salomon, Hendrik Isbarn, Lars Budaeus, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|May 7, 2024
Impact of COVID-19 on the time to counseling and treatment of prostate cancerDejan K Filipas, Randi M Pose, Phillip Marks, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Aktuelle Urologie|June 1, 2021
[Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance]Marie Christine Hupe, Marten Müller, Julian Peter Struck, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
Aktuelle Urologie|September 24, 2020
[CARD study: relevance for the treatment of advanced prostate cancer]Axel S Merseburger, Andreas Bannowsky, Klaus Becker, et al.
Pageof 21